A United Kingdom supplier, with 2 awarded contracts, totalling £2, most recently 9 months ago.
This contract involves a non-exclusive discount agreement between IKK classic and Egetis Therapeutics AB for the medication Emcitate(R), which contains the active ingredient Tiratricol (ATC code: H03AA04). The agreement is set to run from September 1, 2025, to August 31, 2027. Suppliers are invited
This contract pertains to the procurement of the medicine Emcitate, as part of a framework discount agreement between health insurance companies and pharmaceutical companies. The GWQ ServicePlus AG, acting on behalf of its shareholder and client health insurance funds, is conducting a formal procure
